Ras family GTPases are critical components of cell regulatory systems that control proliferation, differentiation, and cell survival. Inappropriate regulation of these systems directly contributes to initiation and progression of human cancer. This proposal is directed at decoding the composition, organization, and function of cell regulatory networks engaged by Ras family GTPases. Our focus is on isolation of molecular fulcrums that can be exploited to deflect oncogenic Ras-induced corruption of cell proliferation and survival restraints.
Our specific aims are 1) mechanistic elaboration of TBK1 as an oncology target in oncogenic Ras associated cancers;2) capture of oncogenic Ras synthetic-lethal loci by matrix analysis of pangenomic RNAi screens;and 3) comprehensive mapping of the human kinome to EGF receptor signaling.

Public Health Relevance

Progress in annotation of the signaling repertoire of oncogenic Ras in human cancer presents an exciting opportunity to identify effective interventions for tumors harboring this mutation. The key bottleneck to progress has been the struggle to identify effective targetable pressure-points within the oncogenic Ras regulatory network. We are applying leading-edge strategies to decode the linchpin elements mediating oncogenic Ras transformation. The expected outcomes and impact of our proposal will be isolation of molecular fulcrums, selectively supporting oncogenic Ras-induced perturbation of regulatory networks, that can be exploited to undercut tumor cell proliferation and survival. We have extensive experience and institutional support to carry out this project.

National Institute of Health (NIH)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Watson, Joanna M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
Anatomy/Cell Biology
Schools of Medicine
United States
Zip Code
Eskiocak, Banu; Ali, Aktar; White, Michael A (2014) The estrogen-related receptor ? inverse agonist XCT 790 is a nanomolar mitochondrial uncoupler. Biochemistry 53:4839-46
Ram, Rosalyn R; Mendiratta, Saurabh; Bodemann, Brian O et al. (2014) RASSF1A inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression. Mol Cell Biol 34:2350-8
Kim, Hyun Seok; Minna, John D; White, Michael A (2013) GWAS meets TCGA to illuminate mechanisms of cancer predisposition. Cell 152:387-9
Bodemann, Brian O; White, Michael A (2013) Ras GTPases: codon bias holds KRas down but not out. Curr Biol 23:R17-20
Potts, Malia B; Kim, Hyun Seok; Fisher, Kurt W et al. (2013) Using functional signature ontology (FUSION) to identify mechanisms of action for natural products. Sci Signal 6:ra90
Kim, Hyun Seok; Mendiratta, Saurabh; Kim, Jiyeon et al. (2013) Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer. Cell 155:552-66
Bodemann, Brian O; Orvedahl, Anthony; Cheng, Tzuling et al. (2011) RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly. Cell 144:253-67
Eskiocak, Ugur; Kim, Sang Bum; Ly, Peter et al. (2011) Functional parsing of driver mutations in the colorectal cancer genome reveals numerous suppressors of anchorage-independent growth. Cancer Res 71:4359-65
Ou, Yi-Hung; Torres, Michael; Ram, Rosalyn et al. (2011) TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. Mol Cell 41:458-70
Whitehurst, Angelique W; Xie, Yang; Purinton, Scott C et al. (2010) Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation. Cancer Res 70:7652-61

Showing the most recent 10 out of 42 publications